Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t-cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer , mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Tags: Donors & Volunteers, Obliteride
Tags: Chronic Myeloid Leukemia, Clinical Research, David G Maloney, Eric Chow, fertility after cancer, Gary Lyman, Glenda Gray, HVTN, immunotherapy, Jennifer Adair, Jerald P Radich, merkel cell carcinoma, Obliteride, Paul Nghiem, Peter Nelson, precision medicine, Prostate Cancer, Vaccine and Infectious Disease Division (VIDD)
(RSS feeds are best viewed in browsers other than Chrome)
Six misconceptions about colorectal cancer
Luke Timmerman to scale Mount Everest for Fred Hutch research
A message from Dr. Gary Gilliland about cancer research in 2018
Hutch Magazine
Our quarterly magazine
Annual Report
Fiscal year highlights
Science Spotlight
Monthly review of Center-authored papers
Get updates via email.